

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.64747193 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64747193 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 6.40879470 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34590085 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.34590085 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.22753241 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.22753241 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.22753241 |
| 9 | tryptophan metabolic process (GO:0006568) | 6.00425164 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.87592188 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.65934756 |
| 12 | urea cycle (GO:0000050) | 5.41123349 |
| 13 | urea metabolic process (GO:0019627) | 5.41123349 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.31287296 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.22554248 |
| 16 | homocysteine metabolic process (GO:0050667) | 5.14233422 |
| 17 | cysteine metabolic process (GO:0006534) | 5.10201800 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.04288042 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 4.98684997 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 4.96855514 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96173238 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.83806798 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.77959785 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.74394548 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.71219055 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.70522572 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.69607619 |
| 28 | lysine metabolic process (GO:0006553) | 4.66629895 |
| 29 | lysine catabolic process (GO:0006554) | 4.66629895 |
| 30 | protein carboxylation (GO:0018214) | 4.62027615 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.62027615 |
| 32 | amino-acid betaine metabolic process (GO:0006577) | 4.59196425 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.57466973 |
| 34 | indolalkylamine metabolic process (GO:0006586) | 4.56650333 |
| 35 | bile acid metabolic process (GO:0008206) | 4.56435241 |
| 36 | phospholipid efflux (GO:0033700) | 4.53533281 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.49841516 |
| 38 | bile acid and bile salt transport (GO:0015721) | 4.46986910 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.45886270 |
| 40 | amine catabolic process (GO:0009310) | 4.43785334 |
| 41 | cellular biogenic amine catabolic process (GO:0042402) | 4.43785334 |
| 42 | regulation of complement activation (GO:0030449) | 4.38616184 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.36383346 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.36383346 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.36383346 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.35419037 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.30121433 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.30121433 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.28656848 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.27406939 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.08627432 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.08627432 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 3.99398735 |
| 54 | coenzyme catabolic process (GO:0009109) | 3.98832265 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.98499131 |
| 56 | NADH metabolic process (GO:0006734) | 3.97822203 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 3.94269430 |
| 58 | cellular glucuronidation (GO:0052695) | 3.90643281 |
| 59 | cholesterol efflux (GO:0033344) | 3.90540101 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 3.85932640 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.85155669 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 3.83281200 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 3.81306653 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.81041571 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78640237 |
| 66 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76135413 |
| 67 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76135413 |
| 68 | drug catabolic process (GO:0042737) | 3.75764256 |
| 69 | glycine metabolic process (GO:0006544) | 3.73157921 |
| 70 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71439805 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 3.70828400 |
| 72 | ethanol oxidation (GO:0006069) | 3.68792727 |
| 73 | drug transmembrane transport (GO:0006855) | 3.66684481 |
| 74 | glutamate metabolic process (GO:0006536) | 3.62117566 |
| 75 | NAD biosynthetic process (GO:0009435) | 3.60029082 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.59076584 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 3.58570409 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.58219210 |
| 79 | organic acid catabolic process (GO:0016054) | 3.58059642 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.58059642 |
| 81 | arginine metabolic process (GO:0006525) | 3.57880420 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.57516841 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.57285530 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.56883378 |
| 85 | fatty acid oxidation (GO:0019395) | 3.56823445 |
| 86 | fatty acid beta-oxidation (GO:0006635) | 3.55914539 |
| 87 | protein-lipid complex assembly (GO:0065005) | 3.55340952 |
| 88 | cholesterol homeostasis (GO:0042632) | 3.54146081 |
| 89 | carnitine metabolic process (GO:0009437) | 3.53496388 |
| 90 | valine metabolic process (GO:0006573) | 3.53349622 |
| 91 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53003403 |
| 92 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53003403 |
| 93 | urate metabolic process (GO:0046415) | 3.52452704 |
| 94 | intestinal cholesterol absorption (GO:0030299) | 3.52320852 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.51340792 |
| 96 | lipid oxidation (GO:0034440) | 3.50243726 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.49718135 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.48461440 |
| 99 | sterol homeostasis (GO:0055092) | 3.47409086 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46925458 |
| 101 | cofactor catabolic process (GO:0051187) | 3.46252828 |
| 102 | pinocytosis (GO:0006907) | 3.46149232 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.45878076 |
| 104 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.15272187 |
| 105 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.12655228 |
| 106 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05228207 |
| 107 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99776473 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 2.94407056 |
| 109 | fructose metabolic process (GO:0006000) | 2.85517068 |
| 110 | proline biosynthetic process (GO:0006561) | 2.81721340 |
| 111 | angiotensin maturation (GO:0002003) | 2.79488313 |
| 112 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.77430192 |
| 113 | oxaloacetate metabolic process (GO:0006107) | 2.76905727 |
| 114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73913132 |
| 115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73913132 |
| 116 | modulation by symbiont of host immune response (GO:0052553) | 2.73913132 |
| 117 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73913132 |
| 118 | modulation by symbiont of host defense response (GO:0052031) | 2.73913132 |
| 119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73913132 |
| 120 | detection of other organism (GO:0098543) | 2.72724550 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 2.71714374 |
| 122 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68887608 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62504801 |
| 124 | detection of bacterium (GO:0016045) | 2.62462090 |
| 125 | glycosphingolipid catabolic process (GO:0046479) | 2.62262689 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62193363 |
| 127 | protein localization to endosome (GO:0036010) | 2.61847100 |
| 128 | pentose-phosphate shunt (GO:0006098) | 2.58656912 |
| 129 | protein-lipid complex subunit organization (GO:0071825) | 2.56685121 |
| 130 | mannose metabolic process (GO:0006013) | 2.56535586 |
| 131 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.55397355 |
| 132 | tricarboxylic acid metabolic process (GO:0072350) | 2.55086986 |
| 133 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.54114312 |
| 134 | response to peptidoglycan (GO:0032494) | 2.53342975 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.52699421 |
| 136 | response to thyroid hormone (GO:0097066) | 2.52398393 |
| 137 | embryonic process involved in female pregnancy (GO:0060136) | 2.51927609 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.51060379 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.50419073 |
| 140 | barbed-end actin filament capping (GO:0051016) | 2.47554262 |
| 141 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.44971779 |
| 142 | acute-phase response (GO:0006953) | 2.43386492 |
| 143 | detection of external biotic stimulus (GO:0098581) | 2.42938284 |
| 144 | glycolipid catabolic process (GO:0019377) | 2.42636342 |
| 145 | epoxygenase P450 pathway (GO:0019373) | 2.40060720 |
| 146 | negative regulation of necroptotic process (GO:0060546) | 2.39786701 |
| 147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.38606467 |
| 148 | diacylglycerol metabolic process (GO:0046339) | 2.38138469 |
| 149 | regulation of necrotic cell death (GO:0010939) | 2.37047989 |
| 150 | regulation of extracellular matrix disassembly (GO:0010715) | 2.36990157 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.35745960 |
| 152 | Golgi transport vesicle coating (GO:0048200) | 2.35029242 |
| 153 | COPI coating of Golgi vesicle (GO:0048205) | 2.35029242 |
| 154 | hemoglobin metabolic process (GO:0020027) | 2.35026727 |
| 155 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.34541286 |
| 156 | proline metabolic process (GO:0006560) | 2.33464100 |
| 157 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31693898 |
| 158 | modulation by symbiont of host cellular process (GO:0044068) | 2.31345246 |
| 159 | detection of molecule of bacterial origin (GO:0032490) | 2.30272590 |
| 160 | NIK/NF-kappaB signaling (GO:0038061) | 2.30265565 |
| 161 | NADPH regeneration (GO:0006740) | 2.28382821 |
| 162 | oligosaccharide catabolic process (GO:0009313) | 2.27421300 |
| 163 | positive regulation of receptor recycling (GO:0001921) | 2.26692964 |
| 164 | regulation of cholesterol storage (GO:0010885) | 2.26058759 |
| 165 | complement activation, classical pathway (GO:0006958) | 2.25720037 |
| 166 | negative regulation of cell killing (GO:0031342) | 2.25542103 |
| 167 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.25542103 |
| 168 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.24982752 |
| 169 | macrophage activation involved in immune response (GO:0002281) | 2.24953912 |
| 170 | intestinal absorption (GO:0050892) | 2.24360085 |
| 171 | negative regulation of viral release from host cell (GO:1902187) | 2.23300501 |
| 172 | regulation of apoptotic cell clearance (GO:2000425) | 2.19486910 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.19401443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.42164513 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76222724 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.47374392 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.85474980 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71972382 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55827214 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.46943888 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73542159 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.43410674 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71430077 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.49678572 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44776688 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22650974 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17812861 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14749596 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.08577773 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07260024 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03580040 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00739026 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3264430 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94477380 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91733821 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90355136 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89212359 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89018781 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87602538 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84215781 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.81823103 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81792616 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80738933 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.78081359 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75942563 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68287454 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.66768962 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54239355 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53508674 |
| 37 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51956005 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51426866 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49560583 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48822298 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47577103 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47460478 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42558750 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42530115 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42337009 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37668783 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37003001 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36321973 |
| 49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33410664 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31586833 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30190531 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30154994 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29001350 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27636298 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26937584 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25885506 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22657329 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22509136 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22147830 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.21251538 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20624357 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19936520 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18300757 |
| 64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14732339 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12889600 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.12538457 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12154679 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10173743 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09701429 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09639378 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09200854 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07405055 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06192336 |
| 74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06185551 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05765717 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05393958 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04681800 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04012233 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02925266 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02204049 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01585813 |
| 82 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00994806 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00598994 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00227817 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 0.99889131 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99676752 |
| 87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99676752 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99454596 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98900263 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98491298 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98126121 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98010717 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97934157 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96829771 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96304216 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96272706 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88855039 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88107376 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84396866 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83489775 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82327668 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81855233 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81607567 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80630597 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78959605 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78889391 |
| 107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77341742 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76601853 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76255739 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75957805 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75683383 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74569288 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.74004483 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73583479 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73360492 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.72464639 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71708262 |
| 118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70961912 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.70866605 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70278203 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69614252 |
| 122 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69115481 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68349878 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68150474 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67987744 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67973605 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67481046 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67481046 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.67328598 |
| 130 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.66850026 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66329450 |
| 132 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65254923 |
| 133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.64730692 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63727269 |
| 135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63414336 |
| 136 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62986067 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62776458 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.61958618 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61539503 |
| 140 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60940372 |
| 141 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.60750805 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.60679136 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.60394713 |
| 144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60337339 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60139646 |
| 146 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58742491 |
| 147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58664521 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.57514152 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56456753 |
| 150 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55143435 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.54999925 |
| 152 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54758572 |
| 153 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54544848 |
| 154 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.54141007 |
| 155 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.54129519 |
| 156 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.53805900 |
| 157 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.53161892 |
| 158 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.52551053 |
| 159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52242745 |
| 160 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.51711047 |
| 161 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51601592 |
| 162 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51512255 |
| 163 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51269134 |
| 164 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51199260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.46741831 |
| 2 | MP0005360_urolithiasis | 7.19994090 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.89360363 |
| 4 | MP0005365_abnormal_bile_salt | 5.79340727 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32999829 |
| 6 | MP0003252_abnormal_bile_duct | 3.86692557 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.42311119 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.26620136 |
| 9 | MP0005083_abnormal_biliary_tract | 2.90763984 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.84908622 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.84791029 |
| 12 | MP0003303_peritoneal_inflammation | 2.68085926 |
| 13 | MP0009840_abnormal_foam_cell | 2.66360581 |
| 14 | MP0003195_calcinosis | 2.59524745 |
| 15 | MP0005332_abnormal_amino_acid | 2.59048449 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.42344913 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.37564258 |
| 18 | MP0000609_abnormal_liver_physiology | 2.07782275 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.97059639 |
| 20 | MP0003868_abnormal_feces_composition | 1.93532507 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.89006504 |
| 22 | MP0005451_abnormal_body_composition | 1.78656513 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.77191878 |
| 24 | MP0001764_abnormal_homeostasis | 1.74494007 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.73970689 |
| 26 | MP0009697_abnormal_copulation | 1.71274002 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.49958332 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.49350419 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48903826 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.48497044 |
| 31 | MP0009764_decreased_sensitivity_to | 1.47591586 |
| 32 | MP0003011_delayed_dark_adaptation | 1.46585302 |
| 33 | MP0005670_abnormal_white_adipose | 1.39674104 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.39432865 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.34441065 |
| 36 | MP0000858_altered_metastatic_potential | 1.29949123 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.29348456 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.27940804 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.27743199 |
| 40 | MP0003186_abnormal_redox_activity | 1.27659308 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.26665709 |
| 42 | MP0004510_myositis | 1.25367416 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.25293970 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.25293970 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.24296038 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.23558436 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.22186996 |
| 48 | MP0002254_reproductive_system_inflammat | 1.20258876 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.15660382 |
| 50 | MP0005647_abnormal_sex_gland | 1.13875032 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.11668330 |
| 52 | MP0005330_cardiomyopathy | 1.10532794 |
| 53 | MP0008469_abnormal_protein_level | 1.10284162 |
| 54 | MP0000598_abnormal_liver_morphology | 1.09150454 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.08312769 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.07294440 |
| 57 | MP0003091_abnormal_cell_migration | 1.06493532 |
| 58 | MP0009763_increased_sensitivity_to | 1.05290454 |
| 59 | MP0003828_pulmonary_edema | 1.04186684 |
| 60 | MP0002723_abnormal_immune_serum | 1.03084326 |
| 61 | MP0009278_abnormal_bone_marrow | 1.01767493 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.01670548 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.01471363 |
| 64 | MP0001819_abnormal_immune_cell | 1.00606099 |
| 65 | MP0002148_abnormal_hypersensitivity_rea | 0.98795333 |
| 66 | MP0005076_abnormal_cell_differentiation | 0.97442903 |
| 67 | MP0003075_altered_response_to | 0.97075748 |
| 68 | MP0002398_abnormal_bone_marrow | 0.96789328 |
| 69 | MP0000749_muscle_degeneration | 0.96517712 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.96111812 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.96107299 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.95811151 |
| 73 | MP0004147_increased_porphyrin_level | 0.94962541 |
| 74 | MP0002971_abnormal_brown_adipose | 0.92093548 |
| 75 | MP0003724_increased_susceptibility_to | 0.92010685 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.90295298 |
| 77 | MP0003866_abnormal_defecation | 0.90073544 |
| 78 | MP0001849_ear_inflammation | 0.89924246 |
| 79 | MP0005334_abnormal_fat_pad | 0.89362666 |
| 80 | MP0004233_abnormal_muscle_weight | 0.88539381 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.88255058 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.88001601 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.87966908 |
| 84 | MP0005023_abnormal_wound_healing | 0.87700691 |
| 85 | MP0002722_abnormal_immune_system | 0.87484794 |
| 86 | MP0004036_abnormal_muscle_relaxation | 0.87289575 |
| 87 | MP0004130_abnormal_muscle_cell | 0.86677574 |
| 88 | MP0001661_extended_life_span | 0.85702202 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.85668604 |
| 90 | MP0003436_decreased_susceptibility_to | 0.85634687 |
| 91 | MP0000747_muscle_weakness | 0.85391054 |
| 92 | MP0000490_abnormal_crypts_of | 0.85329458 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.84070134 |
| 94 | MP0000716_abnormal_immune_system | 0.84041426 |
| 95 | MP0000343_altered_response_to | 0.83777788 |
| 96 | MP0002405_respiratory_system_inflammati | 0.83168098 |
| 97 | MP0002429_abnormal_blood_cell | 0.82078580 |
| 98 | MP0004858_abnormal_nervous_system | 0.79959680 |
| 99 | MP0000751_myopathy | 0.79706993 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.79540329 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.79199004 |
| 102 | MP0001756_abnormal_urination | 0.78317501 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.76686975 |
| 104 | MP0009785_altered_susceptibility_to | 0.75842452 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.74545590 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.71876516 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.70690768 |
| 108 | MP0002928_abnormal_bile_duct | 0.69124508 |
| 109 | MP0002132_abnormal_respiratory_system | 0.68856626 |
| 110 | MP0005535_abnormal_body_temperature | 0.68278415 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.65944744 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.65605115 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.64024879 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.62043168 |
| 115 | MP0005448_abnormal_energy_balance | 0.61661706 |
| 116 | MP0005408_hypopigmentation | 0.61015940 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.61013219 |
| 118 | MP0005387_immune_system_phenotype | 0.60190018 |
| 119 | MP0001790_abnormal_immune_system | 0.60190018 |
| 120 | MP0005025_abnormal_response_to | 0.59393164 |
| 121 | MP0000685_abnormal_immune_system | 0.59043654 |
| 122 | MP0001873_stomach_inflammation | 0.58216988 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.58137784 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.55609042 |
| 125 | MP0000604_amyloidosis | 0.55543306 |
| 126 | MP0004381_abnormal_hair_follicle | 0.55474916 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.52873210 |
| 128 | MP0002419_abnormal_innate_immunity | 0.52864273 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.51924264 |
| 130 | MP0009115_abnormal_fat_cell | 0.50077090 |
| 131 | MP0002837_dystrophic_cardiac_calcinosis | 0.49572375 |
| 132 | MP0005266_abnormal_metabolism | 0.48860948 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.48361071 |
| 134 | MP0001853_heart_inflammation | 0.48042189 |
| 135 | MP0006082_CNS_inflammation | 0.47549421 |
| 136 | MP0002166_altered_tumor_susceptibility | 0.46951826 |
| 137 | MP0001800_abnormal_humoral_immune | 0.45837631 |
| 138 | MP0005395_other_phenotype | 0.45816204 |
| 139 | MP0002168_other_aberrant_phenotype | 0.44686494 |
| 140 | MP0004947_skin_inflammation | 0.44602738 |
| 141 | MP0003953_abnormal_hormone_level | 0.41869525 |
| 142 | MP0002060_abnormal_skin_morphology | 0.40565962 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.39866426 |
| 144 | MP0005058_abnormal_lysosome_morphology | 0.39188443 |
| 145 | MP0000579_abnormal_nail_morphology | 0.39049467 |
| 146 | MP0000427_abnormal_hair_cycle | 0.38007024 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.37982274 |
| 148 | MP0005166_decreased_susceptibility_to | 0.37325441 |
| 149 | MP0001663_abnormal_digestive_system | 0.35139647 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.35040912 |
| 151 | MP0008260_abnormal_autophagy | 0.34249272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.43678548 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.20182617 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.93974601 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.74845806 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.72753746 |
| 6 | Xanthomatosis (HP:0000991) | 5.53292528 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.24306414 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.99944273 |
| 9 | Complement deficiency (HP:0004431) | 4.60697189 |
| 10 | Joint hemorrhage (HP:0005261) | 4.46123647 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36726070 |
| 12 | Hyperammonemia (HP:0001987) | 4.27313656 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.27151049 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.17734650 |
| 15 | Ketosis (HP:0001946) | 4.03618725 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.03553222 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.03107487 |
| 18 | Hyperglycinemia (HP:0002154) | 4.00363499 |
| 19 | Hyperglycinuria (HP:0003108) | 3.99812925 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.96603774 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95631621 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89515189 |
| 23 | Fat malabsorption (HP:0002630) | 3.87209371 |
| 24 | Epidermoid cyst (HP:0200040) | 3.84587071 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.78782822 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.75887770 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75887770 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.65974079 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.61846198 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56815924 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48435077 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.42669249 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.40864242 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39068561 |
| 35 | Abnormality of complement system (HP:0005339) | 3.29078873 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.22692153 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18591768 |
| 38 | Metabolic acidosis (HP:0001942) | 3.05628609 |
| 39 | Ketoacidosis (HP:0001993) | 3.04024558 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.99479690 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95223577 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 2.95223577 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.93326775 |
| 44 | Acanthocytosis (HP:0001927) | 2.92314226 |
| 45 | Steatorrhea (HP:0002570) | 2.88853014 |
| 46 | Myocardial infarction (HP:0001658) | 2.88560058 |
| 47 | Vascular calcification (HP:0004934) | 2.86377789 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.85139449 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.83322342 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.83175529 |
| 51 | Poikilocytosis (HP:0004447) | 2.78234651 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.69350778 |
| 53 | Polycythemia (HP:0001901) | 2.68239762 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.67285130 |
| 55 | Renal cortical cysts (HP:0000803) | 2.65886628 |
| 56 | Recurrent abscess formation (HP:0002722) | 2.63949636 |
| 57 | Increased connective tissue (HP:0009025) | 2.63158395 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62591500 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.61650702 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.58618783 |
| 61 | Spontaneous abortion (HP:0005268) | 2.58062796 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.56476492 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.56355930 |
| 64 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.53976154 |
| 65 | Nemaline bodies (HP:0003798) | 2.53036832 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.52299250 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.51046588 |
| 68 | Cholelithiasis (HP:0001081) | 2.49885845 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.49813895 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.49348008 |
| 71 | Rhabdomyolysis (HP:0003201) | 2.48586893 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 2.47489190 |
| 73 | Gout (HP:0001997) | 2.46838821 |
| 74 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.45336581 |
| 75 | Lethargy (HP:0001254) | 2.43123146 |
| 76 | Gingival bleeding (HP:0000225) | 2.41151846 |
| 77 | Malnutrition (HP:0004395) | 2.37548797 |
| 78 | Cellulitis (HP:0100658) | 2.36495923 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.34678572 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.34678572 |
| 81 | Pancreatitis (HP:0001733) | 2.33972564 |
| 82 | Esophageal varix (HP:0002040) | 2.32208163 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.31251970 |
| 84 | Recurrent bacterial skin infections (HP:0005406) | 2.30966487 |
| 85 | Alkalosis (HP:0001948) | 2.27323961 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.26523487 |
| 87 | Increased serum ferritin (HP:0003281) | 2.26326113 |
| 88 | Enlarged kidneys (HP:0000105) | 2.26241317 |
| 89 | Menorrhagia (HP:0000132) | 2.21021201 |
| 90 | Purpura (HP:0000979) | 2.18032640 |
| 91 | Gingivitis (HP:0000230) | 2.17579416 |
| 92 | Achilles tendon contracture (HP:0001771) | 2.14792827 |
| 93 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14642213 |
| 94 | Colitis (HP:0002583) | 2.14291751 |
| 95 | Hyperuricemia (HP:0002149) | 2.14024640 |
| 96 | Increased purine levels (HP:0004368) | 2.14024640 |
| 97 | Type 1 muscle fiber predominance (HP:0003803) | 2.13851052 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.12597598 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.12284666 |
| 100 | Vomiting (HP:0002013) | 2.11788673 |
| 101 | Cerebral edema (HP:0002181) | 2.11215591 |
| 102 | Mitral stenosis (HP:0001718) | 2.10962537 |
| 103 | Skin nodule (HP:0200036) | 2.10843388 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06930655 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06930655 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06930655 |
| 107 | Glycosuria (HP:0003076) | 2.06807349 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.06807349 |
| 109 | Thrombophlebitis (HP:0004418) | 2.06481848 |
| 110 | Sensorimotor neuropathy (HP:0007141) | 2.06340879 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.06021921 |
| 112 | Elevated hepatic transaminases (HP:0002910) | 2.05506690 |
| 113 | Petechiae (HP:0000967) | 2.04340903 |
| 114 | Nausea (HP:0002018) | 2.04263342 |
| 115 | Dysostosis multiplex (HP:0000943) | 2.03757666 |
| 116 | Ileus (HP:0002595) | 2.02503053 |
| 117 | Rickets (HP:0002748) | 2.02240353 |
| 118 | Opisthotonus (HP:0002179) | 2.00710577 |
| 119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.00415775 |
| 120 | Symptomatic seizures (HP:0011145) | 2.00367039 |
| 121 | Glomerulonephritis (HP:0000099) | 2.00242271 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99949368 |
| 123 | Myopathic facies (HP:0002058) | 1.99411565 |
| 124 | Late onset (HP:0003584) | 1.98938684 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.98185615 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.98025143 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96630115 |
| 128 | Pigmentary retinal degeneration (HP:0001146) | 1.94300848 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93794151 |
| 130 | Orchitis (HP:0100796) | 1.92099662 |
| 131 | Fatigue (HP:0012378) | 1.91520745 |
| 132 | Myositis (HP:0100614) | 1.90995289 |
| 133 | Irritability (HP:0000737) | 1.90807663 |
| 134 | Reticulocytosis (HP:0001923) | 1.90340763 |
| 135 | Prolonged bleeding time (HP:0003010) | 1.90183871 |
| 136 | Cholecystitis (HP:0001082) | 1.90100102 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.90100102 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90044636 |
| 139 | Amyloidosis (HP:0011034) | 1.88697458 |
| 140 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88326908 |
| 141 | Mucopolysacchariduria (HP:0008155) | 1.88326908 |
| 142 | Thin bony cortex (HP:0002753) | 1.87179372 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.87022625 |
| 144 | Epistaxis (HP:0000421) | 1.86978857 |
| 145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84943439 |
| 146 | Osteolytic defects of the hand bones (HP:0009699) | 1.84943439 |
| 147 | Osteomyelitis (HP:0002754) | 1.83147362 |
| 148 | Flat acetabular roof (HP:0003180) | 1.82906386 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82349845 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82349845 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82349845 |
| 152 | Gastrointestinal stroma tumor (HP:0100723) | 1.82235251 |
| 153 | Hypochromic anemia (HP:0001931) | 1.82111999 |
| 154 | Hyporeflexia of lower limbs (HP:0002600) | 1.76074660 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.75465764 |
| 156 | Abnormality of the thoracic spine (HP:0100711) | 1.74993154 |
| 157 | Cerebral aneurysm (HP:0004944) | 1.72933165 |
| 158 | Recurrent viral infections (HP:0004429) | 1.71601744 |
| 159 | Obstructive lung disease (HP:0006536) | 1.71229086 |
| 160 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71229086 |
| 161 | Meningitis (HP:0001287) | 1.71220758 |
| 162 | Mediastinal lymphadenopathy (HP:0100721) | 1.70041787 |
| 163 | Gastrointestinal inflammation (HP:0004386) | 1.69961619 |
| 164 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69687627 |
| 165 | Neck muscle weakness (HP:0000467) | 1.68802805 |
| 166 | Ragged-red muscle fibers (HP:0003200) | 1.68116250 |
| 167 | Increased cerebral lipofuscin (HP:0011813) | 1.67019660 |
| 168 | EMG: myopathic abnormalities (HP:0003458) | 1.65765288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.11240581 |
| 2 | PRPF4B | 3.71272288 |
| 3 | ERN1 | 3.59582415 |
| 4 | INSRR | 3.44021894 |
| 5 | FGFR4 | 3.29095360 |
| 6 | SMG1 | 3.05812969 |
| 7 | MST1R | 3.02902786 |
| 8 | SIK1 | 2.95768173 |
| 9 | TAOK3 | 2.79277588 |
| 10 | MAP3K14 | 2.74939342 |
| 11 | FRK | 2.34010571 |
| 12 | EEF2K | 2.23166160 |
| 13 | TTN | 2.17141774 |
| 14 | IRAK3 | 2.14603144 |
| 15 | TYK2 | 2.09228281 |
| 16 | PIK3CA | 1.97765226 |
| 17 | FLT3 | 1.85280291 |
| 18 | PIK3CG | 1.81624206 |
| 19 | TBK1 | 1.76157574 |
| 20 | ICK | 1.72872648 |
| 21 | MAPK11 | 1.69354653 |
| 22 | NME2 | 1.66595093 |
| 23 | EPHA3 | 1.65449952 |
| 24 | PRKAA2 | 1.55105654 |
| 25 | JAK1 | 1.53402065 |
| 26 | ERBB4 | 1.53240761 |
| 27 | IKBKE | 1.52970459 |
| 28 | TAOK1 | 1.49749270 |
| 29 | GRK1 | 1.46833228 |
| 30 | NEK9 | 1.38459690 |
| 31 | MAP2K3 | 1.36914174 |
| 32 | RIPK4 | 1.35786337 |
| 33 | MAP3K1 | 1.32024534 |
| 34 | LATS1 | 1.21552507 |
| 35 | PTK6 | 1.19740782 |
| 36 | MAP3K7 | 1.18089594 |
| 37 | KSR2 | 1.15765654 |
| 38 | SCYL2 | 1.15533425 |
| 39 | ZAK | 1.11397913 |
| 40 | MAP3K3 | 1.11222721 |
| 41 | PINK1 | 1.10070251 |
| 42 | EIF2AK1 | 1.09309189 |
| 43 | PKN2 | 1.08843324 |
| 44 | JAK2 | 1.08357846 |
| 45 | IKBKB | 1.08353835 |
| 46 | JAK3 | 1.06773419 |
| 47 | CAMK1D | 1.06718511 |
| 48 | CDC42BPA | 1.05265046 |
| 49 | PDPK1 | 1.03706224 |
| 50 | NUAK1 | 1.01458365 |
| 51 | CDK12 | 1.00953006 |
| 52 | OBSCN | 0.98259167 |
| 53 | MAPKAPK3 | 0.96148474 |
| 54 | EIF2AK2 | 0.95649485 |
| 55 | MAP4K1 | 0.95564885 |
| 56 | PRKAA1 | 0.94203299 |
| 57 | TAOK2 | 0.93524492 |
| 58 | MAP3K13 | 0.93229747 |
| 59 | GRK6 | 0.93111826 |
| 60 | IRAK4 | 0.91545955 |
| 61 | IRAK1 | 0.89773692 |
| 62 | CHUK | 0.88493284 |
| 63 | LRRK2 | 0.87020299 |
| 64 | LMTK2 | 0.85769111 |
| 65 | TRIB3 | 0.84977507 |
| 66 | PAK4 | 0.83278062 |
| 67 | TGFBR2 | 0.82497966 |
| 68 | MAPK12 | 0.82223631 |
| 69 | SGK3 | 0.81865502 |
| 70 | KDR | 0.80672436 |
| 71 | TESK2 | 0.80607699 |
| 72 | SGK2 | 0.80579117 |
| 73 | NLK | 0.79423607 |
| 74 | MAP3K8 | 0.77779318 |
| 75 | TXK | 0.76802481 |
| 76 | MAP3K2 | 0.76093172 |
| 77 | FGFR3 | 0.74817299 |
| 78 | STK38L | 0.73816036 |
| 79 | MAP2K6 | 0.72865781 |
| 80 | MAP2K4 | 0.71523221 |
| 81 | PDGFRA | 0.70506023 |
| 82 | DDR2 | 0.70279373 |
| 83 | CSK | 0.70259532 |
| 84 | MAPK7 | 0.68712667 |
| 85 | PDK1 | 0.68337790 |
| 86 | MAP3K10 | 0.67951690 |
| 87 | EPHA2 | 0.67755477 |
| 88 | MAP2K2 | 0.65621231 |
| 89 | TIE1 | 0.65043096 |
| 90 | MELK | 0.64931294 |
| 91 | MET | 0.64044524 |
| 92 | CSF1R | 0.63380288 |
| 93 | TEC | 0.63142823 |
| 94 | PIM2 | 0.63071961 |
| 95 | HCK | 0.62826283 |
| 96 | STK10 | 0.62742045 |
| 97 | PDK2 | 0.61553841 |
| 98 | BTK | 0.61544555 |
| 99 | EPHB1 | 0.61407274 |
| 100 | MTOR | 0.61376548 |
| 101 | ERBB2 | 0.60882595 |
| 102 | CDK9 | 0.58339803 |
| 103 | PIM1 | 0.58210041 |
| 104 | HIPK2 | 0.57623751 |
| 105 | IRAK2 | 0.57536357 |
| 106 | DYRK1B | 0.57464343 |
| 107 | TRPM7 | 0.57078213 |
| 108 | RIPK1 | 0.56945631 |
| 109 | BLK | 0.56763531 |
| 110 | MAPK15 | 0.55942848 |
| 111 | STK4 | 0.54948342 |
| 112 | TESK1 | 0.52958230 |
| 113 | ABL2 | 0.52774167 |
| 114 | MAPKAPK2 | 0.52419880 |
| 115 | FGR | 0.52251148 |
| 116 | PRKCZ | 0.51375233 |
| 117 | PRKACG | 0.51030215 |
| 118 | PRKCQ | 0.49684026 |
| 119 | PKN1 | 0.49275519 |
| 120 | MAPK4 | 0.48005875 |
| 121 | PRKD2 | 0.47185490 |
| 122 | CDK7 | 0.46123912 |
| 123 | DAPK2 | 0.45336958 |
| 124 | CDK6 | 0.45265491 |
| 125 | CLK1 | 0.45003504 |
| 126 | RPS6KL1 | 0.44420701 |
| 127 | RPS6KC1 | 0.44420701 |
| 128 | MAP3K6 | 0.43689044 |
| 129 | MAP2K1 | 0.43360863 |
| 130 | PRKG2 | 0.42995111 |
| 131 | RET | 0.42115323 |
| 132 | MATK | 0.41674800 |
| 133 | MYLK | 0.40866878 |
| 134 | ITK | 0.39760797 |
| 135 | CDK4 | 0.39640105 |
| 136 | MAP3K5 | 0.38734863 |
| 137 | RAF1 | 0.38712364 |
| 138 | KIT | 0.38543143 |
| 139 | LYN | 0.37761636 |
| 140 | ZAP70 | 0.35956366 |
| 141 | MAP3K11 | 0.35673133 |
| 142 | STK3 | 0.35581412 |
| 143 | SYK | 0.33998297 |
| 144 | CAMK1G | 0.33323852 |
| 145 | GSK3A | 0.33216916 |
| 146 | IGF1R | 0.33154188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13654371 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20283509 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15161181 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.85599531 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79809918 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75511778 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71076467 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55857839 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55016899 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46852154 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35823672 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32085027 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29775512 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20333731 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.19729184 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01775908 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97418768 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95090231 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89059390 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88239735 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86405818 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86097928 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85717488 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79934934 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75733309 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73627416 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69966816 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69579663 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65925405 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56661448 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56361101 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55530492 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.52370145 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50680274 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50606405 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48066065 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47191481 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46461574 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44187706 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43946542 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42580316 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40856850 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39701516 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36255567 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36036486 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35109000 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34529998 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32820747 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31144555 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27444135 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27324971 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25237470 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24898617 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21385267 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13651648 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13440878 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10058308 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 1.09888048 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03305020 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00792885 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.99426928 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.98876202 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98570047 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.97341315 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97199559 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96411362 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.96128827 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96117623 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94699064 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91803252 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91741931 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90397419 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86695646 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.86191093 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86139833 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.86123468 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84568067 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.82708395 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82628773 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80410974 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80066491 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79696270 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79661334 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79244465 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.78531423 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77600974 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74168442 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73509606 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73334018 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.71583347 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68224907 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61118743 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61026824 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59644133 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58870553 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58705540 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58417542 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56988443 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.56020235 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55362258 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.55290483 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54955914 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.54724912 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54080951 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53506843 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53061796 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52955882 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52651622 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51296085 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49885759 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48665080 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48358543 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48316817 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.47787320 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40907223 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38352669 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.37745682 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37371286 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36271503 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24350784 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22074466 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20145651 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.15727775 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.14443573 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13935497 |
| 126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13632710 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.08660887 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08610147 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.07897018 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.07417807 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05878144 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04959357 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03448239 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01585550 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00337139 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.1143662 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1091918 |
| 138 | Influenza A_Homo sapiens_hsa05164 | -0.1017820 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0855955 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0799285 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0714865 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0648295 |
| 143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0423757 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0367217 |
| 145 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0143300 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0105378 |

